248 related articles for article (PubMed ID: 9032471)
1. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
Clezardin P; Lawler J; Amiral J; Quentin G; Delmas P
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
[TBL] [Abstract][Full Text] [Related]
2. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
3. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
Adams JC; Lawler J
Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
[TBL] [Abstract][Full Text] [Related]
4. Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan.
Kaesberg PR; Ershler WB; Esko JD; Mosher DF
J Clin Invest; 1989 Mar; 83(3):994-1001. PubMed ID: 2522106
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
[TBL] [Abstract][Full Text] [Related]
6. Tropoelastin interacts with cell-surface glycosaminoglycans via its COOH-terminal domain.
Broekelmann TJ; Kozel BA; Ishibashi H; Werneck CC; Keeley FW; Zhang L; Mecham RP
J Biol Chem; 2005 Dec; 280(49):40939-47. PubMed ID: 16192266
[TBL] [Abstract][Full Text] [Related]
7. Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1.
Chen H; Sottile J; Strickland DK; Mosher DF
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):959-63. PubMed ID: 8836144
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG.
Gantt SM; Clavijo P; Bai X; Esko JD; Sinnis P
J Biol Chem; 1997 Aug; 272(31):19205-13. PubMed ID: 9235912
[TBL] [Abstract][Full Text] [Related]
9. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.
Voland C; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding domain, type 1 and type 2 repeats of thrombospondin mediate its interaction with human breast cancer cells.
Incardona F; Lawler J; Cataldo D; Panet A; Legrand Y; Foidart JM; Legrand C
J Cell Biochem; 1996 Sep; 62(4):431-42. PubMed ID: 8891889
[TBL] [Abstract][Full Text] [Related]
11. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
Catimel B; Leung L; el Ghissasi H; Mercier N; McGregor J
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins.
Tuszynski GP; Rothman VL; Deutch AH; Hamilton BK; Eyal J
J Cell Biol; 1992 Jan; 116(1):209-17. PubMed ID: 1730745
[TBL] [Abstract][Full Text] [Related]
13. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1.
Kosfeld MD; Frazier WA
J Biol Chem; 1992 Aug; 267(23):16230-6. PubMed ID: 1644809
[TBL] [Abstract][Full Text] [Related]
14. Syndecan binding sites in the laminin alpha1 chain G domain.
Suzuki N; Ichikawa N; Kasai S; Yamada M; Nishi N; Morioka H; Yamashita H; Kitagawa Y; Utani A; Hoffman MP; Nomizu M
Biochemistry; 2003 Nov; 42(43):12625-33. PubMed ID: 14580209
[TBL] [Abstract][Full Text] [Related]
15. The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.
Goicoechea S; Pallero MA; Eggleton P; Michalak M; Murphy-Ullrich JE
J Biol Chem; 2002 Oct; 277(40):37219-28. PubMed ID: 12147682
[TBL] [Abstract][Full Text] [Related]
16. The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.
Chang YC; Chan YH; Jackson DG; Hsieh SL
J Immunol; 2006 Jan; 176(1):173-80. PubMed ID: 16365408
[TBL] [Abstract][Full Text] [Related]
17. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
[TBL] [Abstract][Full Text] [Related]
18. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD
J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183
[TBL] [Abstract][Full Text] [Related]
19. Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain. Evidence for a single calcium-dependent binding site on CD36.
Frieda S; Pearce A; Wu J; Silverstein RL
J Biol Chem; 1995 Feb; 270(7):2981-6. PubMed ID: 7531696
[TBL] [Abstract][Full Text] [Related]
20. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
